Two US Food and Drug Administration Communications Include Resources and Information About Fraudulent Products and Pulse Oximeter Reliability
The US Food and Drug Administration is committed to the continued evaluation of the safety, effectiveness, and availability of medical devices, including devices in high demand during the COVID-19 (coronavirus disease 2019) pandemic. Two recent US Food and Drug Administration communications, shared here, include resources and information that may impact the work of healthcare professionals and healthcare technology managers.
Source: Journal of Clinical Engineering - Category: Medical Devices Tags: FEATURE ARTICLES Source Type: research
More News: Coronavirus | COVID-19 | Food and Drug Administration (FDA) | Medical Devices | Pandemics